Skip to main content

Davis Polk & Wardwell and Global Law Office are advising medical research firm CARsgen Therapeutics on its planned IPO in Hong Kong, with Herbert Smith Freehills and Zhong Lun Law Firm advising the joint underwriters. The IPO is expected to raise up to $400 million.

CARsgen is a biopharmaceutical company established in 2014, with operations in China and the U.S. It focuses on CAR-T cell therapies for the treatment of hematological malignancies and solid tumors.

Maples and Calder is providing the issuer offshore legal advice. The joint underwriters are Goldman Sachs and UBS.

Related Articles

Luthra, AZB, CAM act on JSW Steel’s $482 mln acquisition of ThyssenKrupp Electrical

by Nimitt Dixit |

Luthra and Luthra Law Offices India, along with AZB & Partners, advised a consortium of JSW Steel and JFE Steel Corporation and their JV on their $482.1 million proposed acquisition of ThyssenKrupp Electrical Steel India, which was represented by Cyril Amarchand Mangaldas.

TT&A, Khaitan, AZB guide Macquarie-backed Blueleaf’s $400 mln India solar bet

by Nimitt Dixit |

Talwar Thakore & Associates and AZB & Partners have advised Singapore-based Blueleaf Energy (BLE) on its $400 million investment in 1 gigawatt of solar projects in the northwestern Indian state of Rajasthan owned by Jakson Green, which was represented by Khaitan & Co.

CAM, Trilegal, Khaitan, IndusLaw act on HUL’s $350 mln Minimalist deal

by Nimitt Dixit |

In the first big M&A deal in India this year, leading firm Cyril Amarchand Mangaldas has guided FMCG major Hindustan Unilever (HUL) on its acquisition of 90.5 percent stake in Jaipur-based skincare startup Minimalist for close to $350 million (29.5 billion rupees).